← back to search

Dan Wang

People 's Hospital of Jilin Province · GB
Area of research
Oncology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis, Diabetes, Cardiovascular Risks, and Lipoproteins, and Diabetes Management and Research.
h-index
35
citations
5,318
works
277
NIH funding
primary concept
Medicine
email

Recent publications

A deep learning-based multimodal medical imaging model for breast cancer screening
Scientific Reports 2025cited by 25position: middledoi
High burden of blindness at initial hospitalisation with primary angle-closure glaucoma in a national multicentre study in China
BMJ Open Ophthalmology 2025cited by 5position: middledoi
UTCI assessment of outdoor thermal comfort in Arid-Hot university campuses during summer
Energy and Buildings 2025cited by 3position: middledoi
Improving multi-trait genomic prediction by incorporating local genetic correlations.
2025cited by 3position: contributordoi
Novel and emerging physical treatments for major depressive disorder
Fundamental Research 2025cited by 2position: middledoi
Exploring of laccase-like nanozyme and membrane filters for efficient removal of tetracycline hydrochloride
Chemical Engineering Journal 2024cited by 24position: middledoi
Rg3-lipo biomimetic delivery of paclitaxel enhances targeting of tumors and myeloid-derived suppressor cells
Journal of Clinical Investigation 2024cited by 20position: middledoi
Unveiling the carbonation behavior of T-C3S and M-C3S: A comparative investigation
Construction and Building Materials 2024cited by 12position: middledoi
Genome-Wide Identification and Characterization of Ammonium Transporter (AMT) Genes in Chlamydomonas reinhardtii
Genes 2024cited by 5position: middledoi
Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma
The Oncologist 2024cited by 1position: middledoi
Performance of the Glucose Management Indicator (GMI) in Type 2 Diabetes
Clinical Chemistry 2023cited by 18position: middledoi
Effects of Positive Airway Pressure Therapy on Glycemic Variability in Patients With Type 2 Diabetes and OSA
CHEST Journal 2023cited by 17position: middledoi
Ciclopirox olamine sensitizes leukemia cells to natural killer cell-mediated cytolysis by upregulating NKG2DLs via the Akt signaling pathway
Biochemical and Biophysical Research Communications 2023cited by 5position: middledoi
China Glaucoma Treatment Pattern Study I–Primary Angle-Closure Glaucoma: protocol for a multicentre, retrospective, observational study
BMJ Open 2023cited by 4position: middledoi
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
Cell Reports 2022cited by 55position: middledoi
Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: results from a longitudinal cohort and mendelian randomization study
The Lancet Regional Health - Western Pacific 2022cited by 55position: middledoi
The Associations of Mean Glucose and Time in Range from Continuous Glucose Monitoring with HbA1c in Adults with Type 2 Diabetes
Diabetes Technology & Therapeutics 2022cited by 10position: middledoi
Metabolomics analysis of the effects of quercetin on Cd-induced hepatotoxicityin rats
Free Radical Research 2022cited by 9position: middledoi
Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018
New England Journal of Medicine 2021cited by 673position: middledoi
Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti–PD-1 Therapy
Frontiers in Cell and Developmental Biology 2021cited by 64position: middledoi
Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States
Kidney International 2021cited by 31position: middledoi
Accurate nomograms with excellent clinical value for locally advanced rectal cancer
Annals of Translational Medicine 2021cited by 11position: middledoi
Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer
Cancer Research and Treatment 2020cited by 108position: middledoi
Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors
Journal of Pancreatic Cancer 2020cited by 49position: middledoi
High-Choline Diet Exacerbates Cardiac Dysfunction, Fibrosis, and Inflammation in a Mouse Model of Heart Failure With Preserved Ejection Fraction
Journal of Cardiac Failure 2020cited by 33position: middledoi
Tiaopi huxin recipe improved endothelial dysfunction and attenuated atherosclerosis by decreasing the expression of caveolin‐1 in ApoE‐deficient mice
Journal of Cellular Physiology 2019cited by 10position: middledoi
The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor
Journal of Translational Medicine 2018cited by 166position: middledoi
Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk
JNCI Journal of the National Cancer Institute 2015cited by 109position: middledoi
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients
Blood 2013cited by 185position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Elizabeth Selvin · Diabetes Care and Research Foundation5 papers (2021–2023)Josef Coresh · Harvard Stem Cell Institute4 papers (2021–2023)Mary R. Rooney · University of Baltimore3 papers (2022–2023)R. Nisha Aurora · New York University3 papers (2022–2023)Changjie Lou · Harbin Medical University3 papers (2020–2024)Michael Fang · University of British Columbia3 papers (2021–2023)Yibing Bai · Chinese PLA General Hospital2 papers (2020–2021)Justin B. Echouffo‐Tcheugui · Welch Foundation2 papers (2022–2023)Zhigang Ma · Harbin Medical University2 papers (2021–2024)Hengzhen Li · Harbin Medical University2 papers (2021–2024)Yanqiao Zhang · Zhejiang Provincial People's Hospital2 papers (2020–2024)Chao Liu · Harbin Medical University2 papers (2020–2021)Xiaonan Xue · Albert Einstein College of Medicine2 papers (2013–2015)Xiaona Fan · Harbin Medical University2 papers (2021–2024)Jiani Yang · Nanjing University of Chinese Medicine2 papers (2020–2021) · 1 papers (2025–2025)Zhuo Chen · Hebei Medical University1 papers (2024–2024)Chao Liu · Nanjing Institute of Technology1 papers (2024–2024)Wenyi Guo · Fudan University1 papers (2023–2023)Xiaoman Ju · Xuzhou Medical College1 papers (2023–2023)